1. Home
  2. NXDT vs NERV Comparison

NXDT vs NERV Comparison

Compare NXDT & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NXDT

NexPoint Diversified Real Estate Trust

HOLD

Current Price

$4.99

Market Cap

259.1M

Sector

Finance

ML Signal

HOLD

Logo Minerva Neurosciences Inc

NERV

Minerva Neurosciences Inc

HOLD

Current Price

$4.56

Market Cap

301.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NXDT
NERV
Founded
2012
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
259.1M
301.6M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
NXDT
NERV
Price
$4.99
$4.56
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$10.50
AVG Volume (30 Days)
145.9K
120.8K
Earning Date
01-01-0001
05-01-2026
Dividend Yield
9.66%
N/A
EPS Growth
N/A
N/A
EPS
0.99
N/A
Revenue
N/A
$41,175,600.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$5.15
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.55
$1.57
52 Week High
$5.61
$12.46

Technical Indicators

Market Signals
Indicator
NXDT
NERV
Relative Strength Index (RSI) 46.14 36.18
Support Level $4.48 $4.30
Resistance Level $5.55 $4.59
Average True Range (ATR) 0.26 0.37
MACD -0.03 0.01
Stochastic Oscillator 19.87 13.70

Price Performance

Historical Comparison
NXDT
NERV

About NXDT NexPoint Diversified Real Estate Trust

NexPoint Diversified Real Estate Trust is an externally advised REIT focused on the acquisition, asset management, development, and disposition of opportunistic, value-add investments in real estate properties throughout the United States. The company has two reportable segments: The Diversified reportable segment is focused on investing in various commercial real estate property types and across the capital structure, including but not limited to, equity, mortgage, debt, mezzanine debt and preferred equity. The Hospitality segment is focused on operating and renovating its U.S. located hospitality assets that meet its investment objective and criteria. Its Portfolio includes investments in the single-family rental, self-storage, office, hospitality, life science and multifamily sectors.

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

Share on Social Networks: